More than 13,500 people contracted COVID-19 in Connecticut between Aug. 1 and Oct. 5, according to the most recent state data ...

New Data to be Presented at IDWeek 2024 Reinforce Merck’s Broad and Diverse Vaccines and Infectious Disease Pipeline and ...

New data published yesterday in Morbidity and Mortality Weekly Report (MMWR) show older adults continue to be hospitalized ...

Molnupiravir, an antiviral drug used to treat patients with COVID-19, appears to be driving SARS-CoV-2 to mutate and evolve, with some of these new viruses being transmitted onwards, a new study ...

With the current batch of omicron subvariants circulating, three treatments are available to patients in the U.S.: Paxlovid, a prescription oral antiviral pill Veklury (remdesivir), an antiviral ...

New research from The Wistar Institute's Salvino lab -; led by professor Joseph Salvino, Ph.D. -; has identified a novel series of SARS-CoV-2 Mpro inhibitors that may lead to potential new COVID-19 ...

Innovative whole system approaches to integrate research and novel technologies within patient pathways are needed to target antibiotic use, minimise healthcare associated infections, and adapt to ...

PhD candidate Momodou Taal is facing expulsion and the termination of his visa for his role in the Cornell University student encampment for Gaza. The Vice Presidential debate was, for many, a ...

Democratic Vice President Kamala Harris led Republican Donald Trump by a marginal three percentage points - 46% to 43% - as the two remain locked in a close race to win the Nov. 5 U.S ...

'People have supported us more than we expected': NC vice president Omar Abdullah "We should wait for the final results to come. Only after that we can say something. As of now, I am really happy ...